|
[1]
|
Luo, Y., Raible, D., Raper, J. and Collapsin, A. (1993) A Protein in Brain That Induces the Collapse and Paralysis of Neuronal Growth Cones. Cell, 75, 217-227. [Google Scholar] [CrossRef]
|
|
[2]
|
Kolodkin, A.L., Matthes, D.J. and Goodman, C.S. (1993) The Semaphorin Genes Encode A Family of Transmembrane and Secreted Growth Cone Guidance Molecules. Cell, 75, 1389-1399. [Google Scholar] [CrossRef]
|
|
[3]
|
Goodman, C.S., Kolodkin, A.L., Luo, Y., Püschel, A.W. and Raper, J.A. (1999) Unified Nomenclature for the Semaphorins/Collapsins. Cell, 97, 551-552. [Google Scholar] [CrossRef]
|
|
[4]
|
Tran, T.S., Kolodkin, A.L. and Bharadwaj, R. (2007) Semaphorin Regulation of Cellular Morphology. Annual Review of Cell and Developmental Biology, 23, 263-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhang, Y., Singh, M.K., Degenhardt, K.R., Lu, M.M., Bennett, J., Yoshida, Y., et al. (2009) Tie2Cre-Mediated Inactivation of PlexinD1 Results in Congenital Heart, Vascular and Skeletal Defects. Developmental Biology, 325, 82-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Rehman, M. and Tamagnone, L. (2013) Semaphorins in Cancer: Biological Mechanisms and Therapeutic Approaches. Seminars in Cell and Developmental Biology, 24, 179-189. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kang, S. and Kumanogoh, A. (2013) Semaphorins in Bone Development, Homeostasis, and Disease. Seminars in Cell and Developmental Biology, 24, 163-171. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hyota, T. and Atsushi, K. (2012) Diverse Roles for Semaphorin-Plexin Signaling in the Immune System. Trends in Immunology, 33, 127-135. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hinck, L. (2004) The Versatile Roles of “Axon Guidance” Cues in Tissue Morphogenesis. Developmental Cell, 7, 783-793. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Villegas, G. and Tufro, A. (2002) Ontogeny of Semaphorins 3A and 3F and Their Receptors Neuropilins 1 and 2 in the Kidney. Mechanisms of Development, 119, S149-S153. [Google Scholar] [CrossRef]
|
|
[11]
|
Perälä, N., Sariola, H. and Immonen, T. (2012) More than Nervous: The Emerging Roles of Plexins. Differentiation: Research in Biological Diversity, 83, 77-91. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Reidy, K.J., Villegas, G., Teichman, J., Veron, D., Shen, W., Jimenez, J., et al. (2009) Semaphorin3a Regulates Endothelial Cell Number and Podocyte Differentiation during Glomerular Development. Development, 136, 3979-3989. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Reidy, K. and Tufro, A. (2011) Semaphorins in Kidney Development and Disease: Modulators of Ureteric Bud Branching, Vascular Morphogenesis, and Podocyte-Endothelial Crosstalk. Pediatric Nephrology, 26, 1407-1412. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kolodkin, A.L., Levengood, D.V., Rowe, E.G., Tai, Y.-T., Giger, R.J. and Ginty, D.D. (1997) Neuropilin Is a Semaphorin III Receptor. Cell, 90, 753-762. [Google Scholar] [CrossRef]
|
|
[15]
|
Guan, F., Villegas, G., Teichman, J., Mundel, P. and Tufro, A. (2006) Autocrine Class 3 Semaphorin System Regulates Slit Diaphragm Proteins and Podocyte Survival. Kidney International, 69, 1564-1569. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Klostermann, A., Lohrum, M., Adams, R.H. and Püschel, A.W. (1998) The Chemorepulsive Activity of the Axonal Guidance Signal Semaphorin D Requires Dimerization. The Journal of Biological Chemistry, 273, 7326-7331. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Gherardi, E., Love, C.A., Esnouf, R.M. and Yvonne Jones, E. (2004) The Sema Domain. Current Opinion in Structural Biology, 14, 669-678. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hota, P.K. and Buck, M. (2012) Plexin Structures Are Coming: Opportunities for Multilevel Investigations of Semaphorin Guidance Receptors, Their Cell Signaling Mechanisms, and Functions. Cellular and Molecular Life Sciences, 69, 3765-3805. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Antipenko, A., Himanen, J.-P., van Leyen, K., Nardi-Dei, V., Lesniak, J., Barton, W.A., et al. (2003) Structure of the Semaphorin-3A Receptor Binding Module. Neuron, 39, 589-598. [Google Scholar] [CrossRef]
|
|
[20]
|
Xia, J. and Thomas, W. (2016) Semaphorins and Plexins in Kidney Disease. Nephron, 132, 93-100. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Tufro, A., Norwood, V.F., Carey, R.M. and and Ariel Gomez, R. (1999) Vascular Endothelial Growth Factor Induces Nephrogenesis and Vasculogenesis. Journal of the American Society of Nephrology, 10, 2125-2134. [Google Scholar] [CrossRef]
|
|
[22]
|
Tufró, A. (2000) VEGF Spatially Directs Angiogenesis during Metanephric Development in Vitro. Developmental Biology, 227, 558-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Robert, B., Zhao, X. and Abrahamson, D.R. (2000) Coexpression of Neuropilin-1, Flk1, and VEGF(164) in Developing and Mature Mouse Kidney Glomeruli. American Journal of Physiology-Renal Physiology, 279, F275-F282. [Google Scholar] [CrossRef]
|
|
[24]
|
Punithavathi, R., Calpurnia, J., Riyaz, M., Weintraub, N.L. and Ramesh, G. (2014) Semaphorin3A-Inactivation Suppresses Ischemia-Reperfusion-Induced Inflammation and Acute Kidney Injury. American Journal of Physiology-Renal Physiology, 307, F183-F194. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Sang, Y., Tsuji, K., Inoue-Torii, A., Fukushima, K., Kitamura, S. and Wada, J. (2020) Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury. International Journal of Molecular Sciences, 21, Article No. 4099. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Grynberg, K., Ma, F.Y. and Nikolic-Paterson, D.J. (2017) The JNK Signaling Pathway in Renal Fibrosis. Frontiers in Physiology, 8, Article No. 829. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Tian, X., Gan, H., Zeng, Y., Zhao, H., Tang, R. and Xia, Y. (2018) Inhibition of Semaphorin-3A Suppresses Lipopolysaccharide-Induced Acute Kidney Injury. Journal of Molecular Medicine, 96, 713-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Chu, C., Deng, J., Man, Y. and Qu, Y. (2017) Green Tea Extracts Epigallocatechin-3-Gallate for Different Treatments. BioMed Research International, 2017, Article ID: 5615647. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Kumagai, K., Hosotani, N., Kikuchi, K., Kimura, T. and Saji, I. (2003) A Novel Semaphorin Inhibitor Produced by a Strain of Penicillium. ChemInform, 34, 610-616. [Google Scholar] [CrossRef]
|
|
[30]
|
Weston, C.R. and Davis, R.J. (2002) The JNK Signal Transduction Pathway. Current Opinion in Genetics & Development, 12, 14-21. [Google Scholar] [CrossRef]
|
|
[31]
|
Weston, C.R. and Davis, R.J. (2007) The JNK Signal Transduction Pathway. Current Opinion in Cell Biology, 19, 142-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Wen, H., Lei, Y., Eun, S.-Y. and Ting, J.P.-Y. (2010) Plexin-A4-Semaphorin 3A Signaling Is Required for Toll-Like Receptor- and Sepsis-Induced Cytokine Storm. The Journal of Experimental Medicine, 207, 2943-2957. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Ogier, J.M., Nayagam, B.A. and Lockhart, P.J. (2020) ASK1 Inhibition: A Therapeutic Strategy with Multi-System Benefits. Journal of molecular medicine, 98, 335-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Ning, L., Li Z. and Wei, D. (2018) Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention. Brazilian Journal of Medical and Biological Research, 51, Article No. e6487. [Google Scholar] [CrossRef]
|
|
[35]
|
Jayakumar, C., Ranganathan, P., Devarajan, P., Krawczeski, C.D., Looney, S. and Ramesh, G. (2013) Semaphorin 3A Is a New Early Diagnostic Biomarker of Experimental and Pediatric Acute Kidney Injury. PLoS ONE, 8, e58446- e58446. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Iyngkaran, P., Schneider, H., Devarajan, P., Anavekar, N., Krum, H. and Ronco, C. (2012) Cardio-Renal Syndrome: New Perspective in Diagnostics. Seminars in Nephrology, 32, 3-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Zubair, I., Chaiban, J.T. and Krikorian, A. (2017) Novel Insights into the Pathophysiology and Clinical Aspects of Diabetic Nephropathy. Reviews in Endocrine & Metabolic Disorders, 18, 21-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Dai, H., Liu, Q. and Liu, B. (2017) Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy. Journal of Diabetes Research, 2017, Article ID: 2615286. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Donath, M.Y. (2013) Targeting Inflammation in the Treatment of Type 2 Diabetes. Diabetes, Obesity and Metabolism, 15, 193-196. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Babizhayev, M.A., Strokov, I.A., Nosikov, V.V., Savel’yeva, E.L., Sitnikov, V.F., Yegorov, Y.E., et al. (2015) The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients. Cell Biochemistry and Biophysics, 71, 1425-1443. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hung, R.-J. and Terman, J.R. (2011) Extracellular Inhibitors, Repellents, and Semaphorin/Plexin/MICAL-Mediated Actin Filament Disassembly. Cytoskeleton, 68, 415-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Hung, R.-J., Yazdani, U., Yoon, J., Wu, H., Yang, T., Gupta, N., et al. (2010) Mical Links Semaphorins to F-Actin Disassembly. Nature, 463, 823-827. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Aggarwal, P.K., Veron, D., Thomas, D.B., Moeckel, G., Kashgarian, M., et al. (2015) Semaphorin3a Promotes Advanced Diabetic Nephropathy. Diabetes, 64, 1743-1759. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Tapia, R., Guan, F., Gershin, I., Teichman, J., Villegas, G. and Tufro, A. (2008) Semaphorin3a Disrupts Podocyte Foot Processes Causing Acute Proteinuria. Kidney International, 73, 733-740. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Mayra, Y., Montgomery, A.M.P., Diaferia, G.R., Kaido, T., Silletti, S., Perez, B., et al. (2003) Recognition of the Neural Chemoattractant Netrin-1 by Integrins α6β4 and α3β1 Regulates Epithelial Cell Adhesion and Migration. Developmental Cell, 5, 695-707. [Google Scholar] [CrossRef]
|
|
[46]
|
Riyaz, M., Punithavathi, R., Calpurnia, J., Nauta, F.L., Gansevoort, R.T., Weintraub, N.L., et al. (2014) Urinary Semaphorin 3A Correlates with Diabetic Proteinuria and Mediates Diabetic Nephropathy and Associated Inflammation in Mice. Journal of Molecular Medicine, 92, 1245-1256. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Chen, J., Xu, Q., Zhang, W., Zhen, Y., Cheng, F., Hua, G., et al. (2020) MiR-203-3p Inhibits the Oxidative Stress, Inflammatory Responses and Apoptosis of Mice Podocytes Induced by hIgh Glucose through Regulating Sema3A Expression. Open Life Sciences, 15, 939-950. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Zahi, T., Amyn, S., Christian, A., Fortin, I., Matsos, M., Ecker, G.A., et al. (2017) Belimumab Use, Clinical Outcomes and Glucocorticoid Reduction in Patients with Systemic Lupus Erythematosus Receiving Belimumab in Clinical Practice Settings: Results from the Observe Canada Study. Rheumatology International, 37, 865-873. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Anderton, S.M. and Fillatreau, S. (2008) Activated B Cells in Autoimmune Diseases: The Case for a Regulatory Role. Nature Clinical Practice Rheumatology, 4, 657-666. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Curreli, S., Wong, B.S., Latinovic, O., Konstantopoulos, K. and Stamatos, N.M. (2016) Class 3 Semaphorins Induce F-Actin Reorganization in Human Dendritic Cells: Role in cell migration. Journal of Leukocyte Biology, 100, 1323- 1334. [Google Scholar] [CrossRef]
|
|
[51]
|
Catalano, A., Caprari, P., Moretti, S., Faronato, M., Tamagnone, L., Procopio, A., et al. (2006) Semaphorin-3A Is Expressed by Tumor Cells and Alters T-Cell Signal Transduction and Function. Blood, 107, 3321-3329. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Vadasz, Z., Haj, T. and Toubi, E. (2014) The Role of B Regulatory Cells and Semaphorin3A in Atopic Diseases. International Archives of Allergy and Immunology, 163, 245-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Vadasz, Z., Haj, T., Halasz, K., Rosner, I., Slobodin, G., Attias, D., et al. (2012) Semaphorin 3A Is a Marker for Disease Activity and a Potential Immunoregulator in Systemic Lupus Erythematosus. Arthritis Research & Therapy, 14, Article No. R146. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Nakano, S., Morimoto, S., Suzuki, J., Mitsuo, A., Nakiri, Y., Katagiri, A., et al. (2007) Down-Regulation of CD72 and Increased Surface IgG on B Cells in Patients with Lupus Nephritis. Autoimmunity, 40, 9-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Vadasz, Z., Ben-Izhak, O., Bejar, J., Sabo, E., Kessel, A., Storch, S., et al. (2011) The Involvement of Immune Semaphorins and Neuropilin-1 in Lupus Nephritis. Lupus, 20, 1466-1473. [Google Scholar] [CrossRef]
|
|
[56]
|
Bejar, J., Kessler, O., Sabag, A.D., Sabo, E., Itzhak, O.B., Neufeld, G., et al. (2018) Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis. Frontiers in Immunology, 9, Article No. 634. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Ji, J.-D., Park-Min, K.-H. and Lionel, B. (2009) Expression and Function of Semaphorin 3A and Its Receptors in Human Monocyte-Derived Macrophages. Human Immunology, 70, 211-217. [Google Scholar] [CrossRef] [PubMed]
|